Jason Sands

45%
Flag icon
By 2011, Europe, the U.K., India, New Zealand, and South Africa had all banned the use of rosiglitazone, though the FDA continued to allow its sale in the United States with a warning label for patients.
The Diabetes Code: Prevent and Reverse Type 2 Diabetes Naturally
Rate this book
Clear rating
Open Preview